Bloomberg: Athenahealth has five potential bidders

Athenahealth, a network-enabled services company for hospitals and ambulatory clients, has bids from at least five entities, according to a report from Bloomberg. The bidders include Bain Capital, Hellman and Friedman, Clayton, Dubiliar & Rice and TPG.

Elliott Management Corp., which currently owns 9 percent of Athenahealth, is also reportedly considering a bid, according to Bloomberg.

The potential sale of Athenahealth comes after its CEO Jonathan Bush announced he was leaving the company in June after admitting to domestic violence allegations against his former wife.

Final bids are due by the end of the month for the company, though Elliott previously said in May it was prepared to make an offer for $160 per share—above the reported new bids of $135 per share. That previous deal was rumored to be worth around $7 billion.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.